UI Health Care joins COVID-19 booster shot clinical trial

The University of Iowa Health Care has joined a new Phase 2 clinical trial that will test booster vaccines in various combinations to determine which provide the best immune response against existing and emerging COVID-19 variants.

Related Keywords

University Of Iowa Health Care ,Iowa ,United States ,University Of Iowa ,Pat Winokur ,Us Centers For Disease ,National Institute Of Allergy ,Us National Institutes Of Health ,Drug Administration ,Pfizer ,Ui Carver College Of Medicine ,Iowa Health Care ,Iowa City Based ,Vaccine Treatment ,Immunologic Landscape ,National Institute ,Infectious Diseases ,Daily News ,Disease Control ,